Search Orphan Drug Designations and Approvals
-
Generic Name: | gylceryl tri (4-pheynlybutyrate) |
---|---|
Date Designated: | 09/03/2009 |
Orphan Designation: | For intermittent or chronic treatment of patients with cirrhosis and any grade hepatic encephalopathy. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Horizon Therapeutics 1 Horizon Way Deerfield, Illinois 60015 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-